| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 11/13/2008 | WO2007133835A3 Ras mutation and compositions and methods related thereto |
| 11/13/2008 | WO2006009546A3 Method for the production of bio-active substances from the novel actinomycete taxa mar3a and mar3b belonging to the family streptomycetaceae |
| 11/13/2008 | WO2005094424A3 Use of the pro-peptide domain of lysyl oxidase as a therapeutic agent |
| 11/13/2008 | WO2005072129A3 Production of host cells containing mutiple integrating vectors by serial transduction |
| 11/13/2008 | US20080282363 Methods for producing human antibodies in scid mice |
| 11/13/2008 | US20080280832 Novel Fsh Glycosylation Variant D3n |
| 11/13/2008 | US20080280818 Glycosylation of peptides via o-linked glycosylation sequences |
| 11/13/2008 | US20080280781 Methods and Compositions for Increasing Membrane Permeability |
| 11/13/2008 | US20080280356 Expression vector for use as transformation and gene transfer agent |
| 11/13/2008 | US20080280346 System For the Production of Dimeric Proteins Based on the Transport System of Hemolysin of Escherichia Coli |
| 11/13/2008 | US20080280327 Expression vector comprising nucleotide sequences coding bone morphogenic protein/selectin fusion for use in treatment and prvention of inflammatory diseases |
| 11/13/2008 | US20080280326 Peptide comprising luteinizing hormone releasing hormone activity for use as tool in designing treatments for brain disorders; pesticides |
| 11/13/2008 | US20080280325 Cellulase for use in detergents, textile treatment, paper pulping or for degradation of biomass |
| 11/13/2008 | US20080280324 Glycoengineering in Mushrooms |
| 11/13/2008 | US20080280323 Method for Producing Epidermal Growth Factor Using Fusion Proteins Comprising Fas-1 Domain |
| 11/13/2008 | US20080280322 Transgenic cell for use as bioreactor in production of human estrogen receptor (HER) specific monoclonal antibody for use in targeted destruction of tumor cells |
| 11/13/2008 | US20080280321 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 11/13/2008 | US20080280319 GSH adducts and uses thereof |
| 11/13/2008 | US20080280313 Protozoan serine/threonine kinase for identifying modulators for use in targeted destruction tumor cells; veterinary medicine |
| 11/13/2008 | US20080280301 Using transmembrane serine protease expression as evaluative tool in detection of nervous system stem cells; regenerative medicine; tissue engineering; treating neurodegenerative |
| 11/13/2008 | US20080279985 Enzymes having glycosidase activity and methods of use thereof |
| 11/13/2008 | US20080279980 Fungamyl-like Alpha-Amylase Variants |
| 11/13/2008 | US20080279887 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug. |
| 11/13/2008 | US20080279877 Human papilloma viral (HPV) thermostable fusion for use in developing vaccine for infection prevention; cervical cancer treatment |
| 11/13/2008 | US20080279859 Neurite outgrowth inhibitor -66 receptor (NOGO-66) specific monoclonal antibody for treatment and prevention of nervous system, muscular, tumor and vision disorders |
| 11/13/2008 | US20080279858 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 11/13/2008 | US20080279852 Methods of treatment with glycosylated antibodies |
| 11/13/2008 | US20080279850 Tetraspanin specific immunoglobulin for use in the treatment and prevention of non-burkitt's malignancy |
| 11/13/2008 | US20080279847 Tumor-associated glycoprotein-72 specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 11/13/2008 | CA2723320A1 Il-12 immunotherapy for cancer |
| 11/13/2008 | CA2689535A1 Viral vector and use thereof |
| 11/13/2008 | CA2685698A1 Anti-tissue factor antibodies and compositions with enhanced effector function |
| 11/13/2008 | CA2684906A1 Cancerous disease modifying antibodies |
| 11/12/2008 | EP1990415A1 Osteoprotegerin |
| 11/12/2008 | EP1990413A1 Screening method for candidate drugs |
| 11/12/2008 | EP1990058A1 Aglyco products and their use for inhibiting infection by influenza virus, and useof hexosamine precursor in schizophrenia treatment |
| 11/12/2008 | EP1990057A1 Beta-secretase substrates and uses thereof |
| 11/12/2008 | EP1989330A2 Alpha-synuclein kinase |
| 11/12/2008 | EP1989232A1 Cytotoxicity mediation of cells evidencing surface expression of cd59 |
| 11/12/2008 | EP1797186A4 Expression system, components thereof and methods of use |
| 11/12/2008 | EP1740700B1 Exo-endo cellulase fusion protein |
| 11/12/2008 | EP1561759B1 Cell death-inducing agent |
| 11/12/2008 | EP1523582B1 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 11/12/2008 | EP1478738B1 Anti-ccr5 antibody |
| 11/12/2008 | EP1465912B1 Chimeric tnf ligands |
| 11/12/2008 | EP1444349B1 Polypeptides of moraxella (branhamella) catarrhalis |
| 11/12/2008 | EP1395275B1 Beta-secretase substrate and uses thereof |
| 11/12/2008 | EP1392831B1 Moraxella(branhamella) catarrhalis antigens |
| 11/12/2008 | EP1259615B1 Antibodies against eotaxin and their use |
| 11/12/2008 | EP1181351B1 Method of purifying heterologous proteins |
| 11/12/2008 | EP1076097B1 METHOD FOR CONTROLLING CLEAVAGE BY OmpT PROTEASE |
| 11/12/2008 | EP1064551B1 Development of human monoclonal antibodies and uses thereof |
| 11/12/2008 | EP0950712B1 Yeast vectors and process for producing proteins with the use of the same |
| 11/12/2008 | EP0950103B1 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 11/12/2008 | EP0792359B1 Transcription factor e2f-4 |
| 11/12/2008 | EP0750668B1 Novel muteins of ifn-beta |
| 11/12/2008 | EP0701569B1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome |
| 11/12/2008 | CN101305017A Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
| 11/12/2008 | CN101302515A Human antibodies that bind human TNF(alpha) |
| 11/12/2008 | CN101302493A Host CHO cell strain highly effective expressing recombinant protein |
| 11/12/2008 | CN101302251A Cyanea-originated glucoprotein having immunopotentiation activity, preparation and use thereof |
| 11/12/2008 | CN101302247A Method for extracting nosipeptide crude product |
| 11/12/2008 | CN101301466A Medicament for treating AIDS |
| 11/12/2008 | CN100432217C Process for the production of biological substances by perfusion culturing of suspended animal cells |
| 11/12/2008 | CN100432104C Method for making insulin precursors and insulin precursor analogs |
| 11/11/2008 | US7449560 Phosophoinositoglycan binding proteins |
| 11/11/2008 | US7449559 deletion of residues in the CR2 domain of the EGFR ectodomain gives rise to a truncated ectodomain with enhanced affinity for epidermal growth factors such as (EGF) and/or transforming growth factor-I (TGF- alpha ); psoriasis and tumor states |
| 11/11/2008 | US7449557 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 11/11/2008 | US7449554 Antibodies against the PRO4977 polypeptides |
| 11/11/2008 | US7449549 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders |
| 11/11/2008 | US7449546 Dissolving a predetermined quantity of reduced glutathione in an aqueous medium having a pH of between 5.0 and 8.0 to produce a reduced glutathione solution having a predetermined initial concentration; storing solutions of reduced glutathione without allowing oxidation of the glutathione to a disulfides |
| 11/11/2008 | US7449545 Antimicrobial bolisin peptides |
| 11/11/2008 | US7449543 Binds to the polypeptide g34872 or binds to a calcium/calmodulin-dependent kinase II; treatment or diagnosis of central nervous system and bipolar disorders |
| 11/11/2008 | US7449450 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products |
| 11/11/2008 | US7449443 Preparing leucine zipper and coiled-coil proteins in which leucine residues have been replaced with 5,5,5-trifluoroleucines; site-directed mutagenesis; mimetics; improved heat/chemical resistance |
| 11/11/2008 | US7449320 Pullulanase for use in saccharfication of stsrches |
| 11/11/2008 | US7449319 polypeptides having hydrolase enzyme activity, useful in the conversion of cellulose to sugars and/or ethanol |
| 11/11/2008 | US7449318 Bacillus mHKcel cellulase |
| 11/11/2008 | US7449316 UDP-galactose: β-D-galactose-R 4-α-D-galactosyltransferase, α4Gal-T1 |
| 11/11/2008 | US7449311 Fermenting macedocin for use as bacteriocin in packaged, canned and ready to eat foods; prevention of food spoilage |
| 11/11/2008 | US7449310 For conferring protective immunity against F. necrophorum |
| 11/11/2008 | US7449191 Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
| 11/11/2008 | US7449187 Alkaline protease from Bacillus gibsonii (DSM 14391) and washing and cleaning products comprising said alkaline protease |
| 11/11/2008 | US7449185 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders |
| 11/11/2008 | US7449183 Endothelialization of vascular surfaces |
| 11/11/2008 | US7449178 Attenuated gram negative bacteria |
| 11/11/2008 | US7449176 Treatment of inflammatory bowel disease with IFN-γ inhibitors |
| 11/06/2008 | WO2008134343A1 Use of protein hydrolysates to stabilize metalloprotease detergent formulations |
| 11/06/2008 | WO2008133711A2 Random homozygous gene perturbation to enhance antibody production |
| 11/06/2008 | WO2008133141A1 Osmotin recombinant protein, method for production of the same, and use of the same |
| 11/06/2008 | WO2008132743A2 Production of high mannose proteins in plant culture |
| 11/06/2008 | WO2008131938A1 Peptidases from basidiomycetes |
| 11/06/2008 | WO2008115750A3 Compositions and methods for the treatment of cancer |
| 11/06/2008 | WO2008112922A3 Methods for generation of antibodies |
| 11/06/2008 | WO2008112092A3 Production of glycoproteins with modified fucosylation |
| 11/06/2008 | WO2008109689A3 Methods for identifying agents of use in treating obesity and diabetes |
| 11/06/2008 | WO2008105773A3 System for targeted delivery of therapeutic agents |
| 11/06/2008 | WO2008094437A3 Chimeric peptide antagonist for gpcr135 or gpcr142 |
| 11/06/2008 | WO2008091911A3 Use of antibody conjugates |
| 11/06/2008 | WO2008085900A3 Methods for generating novel stabilized proteins |